Cargando…

Stereotactic radiotherapy for early stage non-small cell lung cancer

Stereotactic body radiotherapy (SBRT) represents a consolidated treatment option for patients with medically inoperable early stage non-small cell lung cancer (NSCLC). The clinical evidence accumulated in the past decade supports its use as an alternative to surgery with comparable survival outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ricardi, Umberto, Badellino, Serena, Filippi, Andrea Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Radiation Oncology 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493429/ https://www.ncbi.nlm.nih.gov/pubmed/26157674 http://dx.doi.org/10.3857/roj.2015.33.2.57

Ejemplares similares

Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach
por: Ricardi, Umberto, et al.
Publicado: (2016)

The Evolving Role of Radiotherapy in Early Stage Hodgkin’s Lymphoma
por: Ricardi, Umberto, et al.
Publicado: (2014)

Modern Radiation Therapy for the Management of Brain Metastases From Non-Small Cell Lung Cancer: Current Approaches and Future Directions
por: Mantovani, Cristina, et al.
Publicado: (2021)

Role of Radiosurgery and Stereotactic Ablative Radiotherapy for Oligometastatic Non-Oncogene Addicted NSCLC
por: Badellino, Serena, et al.
Publicado: (2022)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis
por: Poon, Ian, et al.
Publicado: (2020)

Proton-Based Stereotactic Ablative Radiotherapy in Early-Stage Non-Small-Cell Lung Cancer
por: Grant, Jonathan D., et al.
Publicado: (2014)

Dose matters for stereotactic body radiotherapy for early stage non-small cell lung cancer
por: Okoye, Christian C., et al.
Publicado: (2020)

Approach and assessment of automated stereotactic radiotherapy planning for early stage non-small-cell lung cancer
por: Bai, Xue, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer
por: Mayne, Nicholas R., et al.
Publicado: (2020)

Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research
por: Vlaskou Badra, Eugenia, et al.
Publicado: (2021)

Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2016)

Stereotactic Body Radiotherapy for Early Stage Lung Cancer
por: Nagata, Yasushi
Publicado: (2013)

Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease
por: Liu, Yuanjun, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy for Early-Stage Non–Small Cell Lung Cancer: When and Why Is It Appropriate Therapy?
por: Mullins, Kim
Publicado: (2015)

Late metastatic presentation is associated with improved survival and delayed wide‐spread progression after ablative stereotactic body radiotherapy for oligometastasis
por: Chen, Xuguang, et al.
Publicado: (2021)

Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea
por: Song, Sanghyuk, et al.
Publicado: (2017)

Comparison of Oncologic Outcomes between Carbon Ion Radiotherapy and Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
por: Miyasaka, Yuhei, et al.
Publicado: (2021)

The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
por: Dahele, Max, et al.
Publicado: (2011)

Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer
por: Verstegen, Naomi E., et al.
Publicado: (2016)

Limited Stage Follicular Lymphoma: Current Role of Radiation Therapy
por: Filippi, Andrea Riccardo, et al.
Publicado: (2016)

Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer
por: KIM, MIN-JEONG, et al.
Publicado: (2013)

Systematic review of stereotactic body radiotherapy in stage III non-small cell lung cancer
por: Alcibar, Olwen Leaman, et al.
Publicado: (2021)

Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer
por: Liu, Xiaoli, et al.
Publicado: (2023)

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer
por: Sun, Hui, et al.
Publicado: (2023)

Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin’s lymphoma: dosimetric comparison and clinical considerations
por: Fiandra, Christian, et al.
Publicado: (2012)

Dosimetric Selection for Helical Tomotherapy Based Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer or Lung Metastases
por: Chi, Alexander, et al.
Publicado: (2012)

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
por: Gkika, Eleni, et al.
Publicado: (2023)

A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly
por: Wang, Peng, et al.
Publicado: (2016)

Stereotactic ablative radiotherapy as single treatment for early stage non‐small cell lung cancer: A single institution analysis
por: Zheng, Xiaoli, et al.
Publicado: (2021)

Symptomatic radiation-induced rib fractures after stereotactic body radiotherapy for early-stage non-small cell lung cancer
por: Kita, Nozomi, et al.
Publicado: (2023)

Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy
por: Tatekawa, Kotoha, et al.
Publicado: (2014)

Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry
por: Davis, Joanne N., et al.
Publicado: (2015)

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer
por: Zarębska, Izabela, et al.
Publicado: (2023)

Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
por: Chen, Hanbo, et al.
Publicado: (2018)

Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry
por: Davis, Joanne N., et al.
Publicado: (2015)

Clinical and dosimetric factors for symptomatic radiation pneumonitis after stereotactic body radiotherapy for early-stage non-small cell lung cancer
por: Kita, Nozomi, et al.
Publicado: (2023)

Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer
por: Mix, Michael, et al.
Publicado: (2019)

Definition of stereotactic body radiotherapy: Principles and practice for the treatment of stage I non-small cell lung cancer
por: Guckenberger, M., et al.
Publicado: (2013)

Adoption of Stereotactic Body Radiotherapy for Stage IA Non–Small Cell Lung Cancer Across the United States
por: Holmes, Jordan A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jmcotb27ccf6oda5l31068ms68